Rare diseases
Investigational molecules
Locations
Piazzale Ludovico Antonio Scuro 10, 37134 Verona, Italy
The sponsor’s oncology portfolio includes clinical research in metastatic pancreatic ductal adenocarcinoma, with attention to patients whose disease has remained controlled after first-line multiagent chemotherapy. This area reflects interest in maintenance strategies for advanced gastrointestinal malignancy and treatment-sensitive metastatic disease.
Research activity in this field is centered on targeted therapy for chemotherapy-sensitive disease and the clinical management of advanced solid tumours.
Universita Degli Studi Di Verona runs clinical trials in conditions such as Adenocarcinoma pancreas, Depression, among others.
Clinical trials run by this sponsor – those enrolling participants first.
ItalyItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
